Skip to content

In the BioHarmony Drug Report Database

Velmanase alfa

Lamzede (velmanase alfa) is an enzyme pharmaceutical. Velmanase alfa was first approved as Lamzede on 2018-03-23. It has been approved in Europe to treat alpha-mannosidosis.
Trade Name Lamzede
Common Name Velmanase alfa
Indication alpha-mannosidosis
Drug Class Enzymes
Velmanase alfa
Get full access now